ZNTL - Zentalis Pharmaceuticals Llc - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ZNTL is currently covered by 11 analysts with an average price target of $37.33. This is a potential upside of $24.33 (187.15%) from yesterday's end of day stock price of $13.

Zentalis Pharmaceuticals Llc's activity chart (see below) currently has 39 price targets and 58 ratings on display. The stock rating distribution of ZNTL is 90.63% BUY and 9.38% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.9% with an average time for these price targets to be met of 46.58 days.

Highest price target for ZNTL is $70, Lowest price target is $15, average price target is $37.33.

Most recent stock forecast was given by ROBERT DRISCOLL from WEDBUSH on 28-Feb-2024. First documented stock forecast 28-Apr-2020.

Currently out of the existing stock ratings of ZNTL, 29 are a BUY (90.63%), 3 are a HOLD (9.38%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

15

$2 (15.38%)

12

1 months 26 days ago

3/7 (42.86%)

$-0.49 (-3.16%)

85

Buy

46

$33 (253.85%)

46

1 months 26 days ago

3/11 (27.27%)

$30.51 (196.97%)

135

Buy

28

$15 (115.38%)

91

4 months 26 days ago

1/3 (33.33%)

$17.56 (168.20%)

52

Hold

15

$2 (15.38%)

42

5 months 16 days ago

3/7 (42.86%)

$4.8 (47.06%)

25

Buy

36

$23 (176.92%)

50

5 months 16 days ago

1/8 (12.5%)

$25.8 (252.94%)

33

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ZNTL (Zentalis Pharmaceuticals Llc) average time for price targets to be met?

On average it took 46.58 days on average for the stock forecasts to be realized with a an average price target met ratio 29.9

Which analyst has the current highest performing score on ZNTL (Zentalis Pharmaceuticals Llc) with a proven track record?

ANDREW FEIN

Which analyst has the most public recommendations on ZNTL (Zentalis Pharmaceuticals Llc)?

Andrew Fein has 15 price targets and 11 ratings on ZNTL

Which analyst is the currently most bullish on ZNTL (Zentalis Pharmaceuticals Llc)?

Michael Ulz with highest potential upside - $82

Which analyst is the currently most reserved on ZNTL (Zentalis Pharmaceuticals Llc)?

Andrew Berens with lowest potential downside - $2

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?